Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update

Go back to Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update

SmartPros Ltd. (SPRO) Misses Q3 EPS by 3c

November 13, 2023 4:15 PM EST

SmartPros Ltd. (NASDAQ: SPRO) reported Q3 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $25.5 million versus the consensus estimate of $14.97 million.

For earnings history and earnings-related data on SmartPros Ltd. (SPRO) click here.

... More